V
VYNE Therapeutics
VYNE
1.81000
USD
-0.064
(-3.42%)
مغلق
حجم التداول
974
الربح لكل سهم
0
العائد الربحي
0
P/E
2
حجم السوق
40,118,360
الأخبار
العنوان: VYNE Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.